Akari Therapeutics Stock (NASDAQ: AKTX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 25.34K |
Day Range | - - - |
52 Wk Range | 1.08 - 5.50 |
Market Cap | $41.80M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 0.08% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Akari Therapeutics (NASDAQ:AKTX) through any online brokerage.
Other companies in Akari Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX) and Curis (NASDAQ:CRIS).
There is no analysis for Akari Therapeutics.
Akari Therapeutics has a consensus price target of $2.75.
The stock price for Akari Therapeutics (NASDAQ: AKTX) is $3.56 last updated July 15, 2024 at 7:39 PM EDT.
There are no upcoming dividends for Akari Therapeutics.
Akari Therapeutics’s H1 earnings are confirmed for Friday, September 27, 2024.
There is no upcoming split for Akari Therapeutics.
Akari Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.